Clinical Trial: An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07773883) titled 'An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD' on Aug. 14.

Brief Summary: This study is a Phase 3, multi-center, open-label trial to evaluate the long-term safety of solriamfetol in children and adolescents with ADHD.

Study Start Date: Aug. 06

Study Type: INTERVENTIONAL

Condition: ADHD

Intervention: DRUG: Solriamfetol

Solriamfetol capsules, taken once daily

Recruitment Status: ENROLLING_BY_INVITATION

Sponsor: Axsome Therapeutics, Inc.

Disclaimer: Curated by HT Syndication....